Abiochem Biotechnology, established in 2015, is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. With a focus on developing advanced biocatalysis and synthetic biology processes, the company is at the forefront of applying these innovations to large-scale production. Their technologies are extensively utilized across various sectors including medicine, health care products, and pesticides, aiding significantly in the realm of green chemistry.
The company's slogan, "Developing new biocatalysis and synthetic biology processes," succinctly captures its mission and innovation-driven approach. The recent significant investment of CNY300.00M in a Series C funding round on 03 May 2021, led by prominent investors such as Temasek Holdings and CMB International Capital Corporation, positions Abiochem as a promising player with strong growth potential. This funding is likely to bolster their R&D capabilities and expand their market presence, offering a compelling opportunity for strategic investors interested in advancements within green and sustainable technologies.
